Could the low level of expression of the gene encoding skeletal muscle mitofusin-2 account for the metabolic inflexibility of obesity?

G. Mingrone, M. Manco, M. Calvani, M. Castagneto, D. Naon, A. Zorzano

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Aims/hypothesis: In obesity the cellular capacity to switch from using lipid to carbohydrate and vice versa as the energy substrate, known as 'metabolic flexibility', is impaired. Mitofusin 2 (MFN2), a mitochondrial membrane protein, seems to contribute to the maintenance and operation of the mitochondrial network, and its expression is reduced in obesity. The aim of this study was to verify whether MFN2 might be implicated in the metabolic inflexibility of obesity. Materials andmethods: Insulin sensitivity was measured in six morbidly obese women before and 2 years after malabsorptive bariatric surgery (BMI 53.3±10.5 vs 30.3±4.0 kg/m2). Skeletal muscle MFN2, SLC2A4 (formerly known as GLUT4), COX3 (encoding cytochrome c oxidase subunit III) and CS (encoding citrate synthase) mRNA levels were measured by real-time PCR. Results: Following bilio-pancreatic surgery, significant increases in MFN2 mRNA (from 0.4±0.2 to 1.7±1.1 arbitrary units [AU], p=0.019) and SLC2A4 mRNA (0.38±0.12 to 0.76±0.24 AU, p=0.04) were observed, while increases in COX3 mRNA (from 14.2±6.4 to 20.2±12.5 AU) and CS mRNA (from 0.4±0.1 to 0.7±0.3 AU) failed to reach statistical significance. Insulin-mediated whole-body glucose uptake significantly (p-1 min-1 and glucose oxidation rose from 11.1±2.1 to 37.7±4.7 μmol kg fat-free mass-1 min-1 (p2=0.92, p2=0.80, p2=0.61, p

Original languageEnglish
Pages (from-to)2108-2114
Number of pages7
JournalDiabetologia
Volume48
Issue number10
DOIs
Publication statusPublished - Oct 2005

Fingerprint

Skeletal Muscle
Obesity
Gene Expression
Messenger RNA
Citrate (si)-Synthase
Glucose
Bariatric Surgery
Mitochondrial Proteins
Mitochondrial Membranes
Electron Transport Complex IV
Insulin Resistance
Real-Time Polymerase Chain Reaction
Membrane Proteins
Fats
Maintenance
Carbohydrates
Insulin
Lipids

Keywords

  • Glucose oxidation
  • Insulin sensitivity
  • Metabolic inflexibility
  • Mitofusin-2 mRNA expression
  • Morbid obesity

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Could the low level of expression of the gene encoding skeletal muscle mitofusin-2 account for the metabolic inflexibility of obesity? / Mingrone, G.; Manco, M.; Calvani, M.; Castagneto, M.; Naon, D.; Zorzano, A.

In: Diabetologia, Vol. 48, No. 10, 10.2005, p. 2108-2114.

Research output: Contribution to journalArticle

Mingrone, G. ; Manco, M. ; Calvani, M. ; Castagneto, M. ; Naon, D. ; Zorzano, A. / Could the low level of expression of the gene encoding skeletal muscle mitofusin-2 account for the metabolic inflexibility of obesity?. In: Diabetologia. 2005 ; Vol. 48, No. 10. pp. 2108-2114.
@article{7a701a9b40d447a39dc50967f313cadb,
title = "Could the low level of expression of the gene encoding skeletal muscle mitofusin-2 account for the metabolic inflexibility of obesity?",
abstract = "Aims/hypothesis: In obesity the cellular capacity to switch from using lipid to carbohydrate and vice versa as the energy substrate, known as 'metabolic flexibility', is impaired. Mitofusin 2 (MFN2), a mitochondrial membrane protein, seems to contribute to the maintenance and operation of the mitochondrial network, and its expression is reduced in obesity. The aim of this study was to verify whether MFN2 might be implicated in the metabolic inflexibility of obesity. Materials andmethods: Insulin sensitivity was measured in six morbidly obese women before and 2 years after malabsorptive bariatric surgery (BMI 53.3±10.5 vs 30.3±4.0 kg/m2). Skeletal muscle MFN2, SLC2A4 (formerly known as GLUT4), COX3 (encoding cytochrome c oxidase subunit III) and CS (encoding citrate synthase) mRNA levels were measured by real-time PCR. Results: Following bilio-pancreatic surgery, significant increases in MFN2 mRNA (from 0.4±0.2 to 1.7±1.1 arbitrary units [AU], p=0.019) and SLC2A4 mRNA (0.38±0.12 to 0.76±0.24 AU, p=0.04) were observed, while increases in COX3 mRNA (from 14.2±6.4 to 20.2±12.5 AU) and CS mRNA (from 0.4±0.1 to 0.7±0.3 AU) failed to reach statistical significance. Insulin-mediated whole-body glucose uptake significantly (p-1 min-1 and glucose oxidation rose from 11.1±2.1 to 37.7±4.7 μmol kg fat-free mass-1 min-1 (p2=0.92, p2=0.80, p2=0.61, p",
keywords = "Glucose oxidation, Insulin sensitivity, Metabolic inflexibility, Mitofusin-2 mRNA expression, Morbid obesity",
author = "G. Mingrone and M. Manco and M. Calvani and M. Castagneto and D. Naon and A. Zorzano",
year = "2005",
month = "10",
doi = "10.1007/s00125-005-1918-9",
language = "English",
volume = "48",
pages = "2108--2114",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer Verlag",
number = "10",

}

TY - JOUR

T1 - Could the low level of expression of the gene encoding skeletal muscle mitofusin-2 account for the metabolic inflexibility of obesity?

AU - Mingrone, G.

AU - Manco, M.

AU - Calvani, M.

AU - Castagneto, M.

AU - Naon, D.

AU - Zorzano, A.

PY - 2005/10

Y1 - 2005/10

N2 - Aims/hypothesis: In obesity the cellular capacity to switch from using lipid to carbohydrate and vice versa as the energy substrate, known as 'metabolic flexibility', is impaired. Mitofusin 2 (MFN2), a mitochondrial membrane protein, seems to contribute to the maintenance and operation of the mitochondrial network, and its expression is reduced in obesity. The aim of this study was to verify whether MFN2 might be implicated in the metabolic inflexibility of obesity. Materials andmethods: Insulin sensitivity was measured in six morbidly obese women before and 2 years after malabsorptive bariatric surgery (BMI 53.3±10.5 vs 30.3±4.0 kg/m2). Skeletal muscle MFN2, SLC2A4 (formerly known as GLUT4), COX3 (encoding cytochrome c oxidase subunit III) and CS (encoding citrate synthase) mRNA levels were measured by real-time PCR. Results: Following bilio-pancreatic surgery, significant increases in MFN2 mRNA (from 0.4±0.2 to 1.7±1.1 arbitrary units [AU], p=0.019) and SLC2A4 mRNA (0.38±0.12 to 0.76±0.24 AU, p=0.04) were observed, while increases in COX3 mRNA (from 14.2±6.4 to 20.2±12.5 AU) and CS mRNA (from 0.4±0.1 to 0.7±0.3 AU) failed to reach statistical significance. Insulin-mediated whole-body glucose uptake significantly (p-1 min-1 and glucose oxidation rose from 11.1±2.1 to 37.7±4.7 μmol kg fat-free mass-1 min-1 (p2=0.92, p2=0.80, p2=0.61, p

AB - Aims/hypothesis: In obesity the cellular capacity to switch from using lipid to carbohydrate and vice versa as the energy substrate, known as 'metabolic flexibility', is impaired. Mitofusin 2 (MFN2), a mitochondrial membrane protein, seems to contribute to the maintenance and operation of the mitochondrial network, and its expression is reduced in obesity. The aim of this study was to verify whether MFN2 might be implicated in the metabolic inflexibility of obesity. Materials andmethods: Insulin sensitivity was measured in six morbidly obese women before and 2 years after malabsorptive bariatric surgery (BMI 53.3±10.5 vs 30.3±4.0 kg/m2). Skeletal muscle MFN2, SLC2A4 (formerly known as GLUT4), COX3 (encoding cytochrome c oxidase subunit III) and CS (encoding citrate synthase) mRNA levels were measured by real-time PCR. Results: Following bilio-pancreatic surgery, significant increases in MFN2 mRNA (from 0.4±0.2 to 1.7±1.1 arbitrary units [AU], p=0.019) and SLC2A4 mRNA (0.38±0.12 to 0.76±0.24 AU, p=0.04) were observed, while increases in COX3 mRNA (from 14.2±6.4 to 20.2±12.5 AU) and CS mRNA (from 0.4±0.1 to 0.7±0.3 AU) failed to reach statistical significance. Insulin-mediated whole-body glucose uptake significantly (p-1 min-1 and glucose oxidation rose from 11.1±2.1 to 37.7±4.7 μmol kg fat-free mass-1 min-1 (p2=0.92, p2=0.80, p2=0.61, p

KW - Glucose oxidation

KW - Insulin sensitivity

KW - Metabolic inflexibility

KW - Mitofusin-2 mRNA expression

KW - Morbid obesity

UR - http://www.scopus.com/inward/record.url?scp=26244456362&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=26244456362&partnerID=8YFLogxK

U2 - 10.1007/s00125-005-1918-9

DO - 10.1007/s00125-005-1918-9

M3 - Article

VL - 48

SP - 2108

EP - 2114

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 10

ER -